
    
      In this prospective study, twenty subjects will be enrolled. The first ten will receive a
      dose of 100mcg pectin fentanyl nasal spray (Lazanda®). The second ten will receive a dose of
      200mcg pectin fentanyl nasal spray (Lazanda®) if the 100mcg was well tolerated in the first
      ten. In all cases, Lidocaine jelly is used as an local anesthetic in the urethra.
    
  